PLANO & DALLAS UPTOWN, Texas, July 8, 2015 /PRNewswire/ -- Restylane® Lyft by Galderma--a dense, hyaluronic acid filler--received FDA market approval last week. Hyaluronic acid (H.A.) fillers are very popular in the aesthetic world, due to the long-lasting facial correction they provide. Previously marketed as Perlane® L (the L stands for "Lidocaine"), Galderma's densest H.A. formulation Perlane® has been FDA-approved for deep facial tissue implantation since 2007; Perlane® L (with Lidocaine--for treatment comfort) has been FDA-approved since February 2010.
Jefffey Adelglass, M.D., F.A.C.S. is Medical Director and Chief of Surgery at SKINTASTIC Cosmetic Surgery and Laser Skin Care Centers, with locations in Plano and Dallas Uptown. Dr. Adelglass participated as a physician investigator in the early clinical research trials for Restylane® and Perlane®, and has performed many facial rejuvenation treatments using the formulation now known as Restylane® Lyft. He trains other physicians to safely administer Restylane® Lyft and other beauty injectable treatments.
Dr. Adelglass discusses his own experience with Restylane® Lyft: "Restylane's higher-density H.A. filler is an incredibly natural-looking deep-tissue implant. The improvements are almost immediate, and can be very dramatic. Restylane Lyft is injected into the deep cheekbone area where facial fat and muscle have depleted due to aging; this re-fills the lost volume in the cheek area, which re-lifts the skin below. The other Restylane formulations can then be used to fill in the fine lines and to treat the lips, for a complete, non-surgical, liquid facelift."
For a limited time, call SKINTASTIC at 972-620-3223 to schedule a complimentary evaluation, and receive a 20% discount on Restylane® Lyft at SKINTASTIC when you mention this offer. Treatment must be received by July 31, 2015. This offer cannot be combined with other offers; other restrictions may apply.
Experience counts. Dr. Adelglass serves on the medical advisory boards of most U.S. dermal filler companies, including Galderma, the company that produces Restylane® and Restylane® Lyft. He is a prominent researcher, and is often called upon by local and national media and scientific groups on topics of clinical research and recent advances in surgical and non-surgical aesthetic correction.
SKINTASTIC Medical and Surgical Rejuvenation Centers are located in Plano, at 6020 W. Parker Road, Suite 400, Plano, Texas, 75093 (at the Dallas North Tollway), and in Dallas Uptown, at 2523 McKinney Ave, Dallas, TX 75201.
Media Contact: Any questions or comments about this story should be directed to Dr. Adelglass at 972-620-3223, or emailed to email@example.com.
Web site: http://www.skintastic.com.
SOURCE SKINTASTIC Medical and Surgical Rejuvenation Centers